University of Toledo

F&M Bank Announces Leadership Changes and Retirements of Rex Rice, EVP & Chief Lending Officer and Benét Rupp, EVP & Chief Administrative Officer

Retrieved on: 
Wednesday, January 24, 2024
Learning, EVP, Bank, Organization development, Agriculture, Rupp, Business administration, University, Treasury, Strategic planning, PNC, MBA, HR, Postgraduate education, Rex Rice, Defiance College, Marketing, Ohio State University, Farmer, Communication, University of Toledo, Management

ARCHBOLD, Ohio, Jan. 24, 2024 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today announced the retirements of Rex Rice, EVP & Chief Lending Officer and Benét Rupp, EVP & Chief Administrative Officer.

Key Points: 
  • ARCHBOLD, Ohio, Jan. 24, 2024 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today announced the retirements of Rex Rice, EVP & Chief Lending Officer and Benét Rupp, EVP & Chief Administrative Officer.
  • Rex began with the bank in 1981 and has served in a variety of leadership capacities.
  • As Chief Administrative Officer, Mr. Carsey will lead F&M’s deposit and loan operations, digital banking, and customer care functions.
  • Ms. Cover joined the Bank in 2009 and has held a variety of leadership positions within the bank’s marketing function.

Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors

Retrieved on: 
Friday, December 1, 2023
Digital therapeutics, Johnson & Johnson, Biotechnology, GE Research, Autoimmunity, Rheumatology, Internal medicine, Inflammation, Therapy, University, Medical college, Scleroderma, Publication, Patient, University of Toledo, Janssen Pharmaceuticals, Pharmaceutical industry

NEW YORK and BOSTON, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D.

Key Points: 
  • NEW YORK and BOSTON, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D.
  • to the Akari Board of Directors.
  • “Samir is a long-time investor in Akari and brings to us broad life sciences experience and a track record of multiple successful startup companies.
  • I am pleased to welcome him to our Board of Directors at this important time in our company’s development,” said Ray Prudo, M.D., Akari Chairman.

VGI Medical, LLC Announces The Launch of the new SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System, for Sacroiliac Joint Transfixation, at NASS 2023

Retrieved on: 
Wednesday, October 18, 2023
3D, Sacrum, US, US FDA, SI, Rotation, Multimedia, Quality of life, University, VGI, Pain, Patient, Ilium, University of Toledo, NASS, Medical device, 3D printing

LARGO, Fla., Oct. 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC launches the new US FDA 510(k) cleared SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System. The transfixing SiJoin® T4 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the porous trabecular construction is engineered to mimic cancellous bone structure. The implant has an engineered lattice design to achieve 500-700 mm pores, and has undergone post processing to create micro and nano surface structures facilitating the proliferation of osteoblast adhesion and bony in-growth. The SiJoin® T4 Implant is engineered with a dual geometric shape designed to be simultaneously positioned within the illium and sacrum, through the respective cortical wall, providing high surface area contact for fixation. The implant is held against rotation via the stabilizer fins positioned between the opposing illium and sacrum surfaces, and the non-circular cross-section of the main body. The patented novel design of the SiJoin® T4 Implant fixes the sacrum and ilium relative to one another, maintaining the anatomical spacing of the SI joint, providing mechanical support by transfixing the SI joint while biologic fusion occurs.

Key Points: 
  • VGI Medical, LLC announces the launch of the new SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System.
  • VGI's superior engineering and testing has allowed them to design a titanium alloy implant for use in alleviating sacroiliac joint pain and create a simplified process for the surgeon.
  • LARGO, Fla., Oct. 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC launches the new US FDA 510(k) cleared SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System.
  • The transfixing SiJoin® T4 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the porous trabecular construction is engineered to mimic cancellous bone structure.

Doug Shaw Named F&M Bank’s Regional President for the Southern Ohio Market

Retrieved on: 
Thursday, September 21, 2023
Ohio State University, Specialization, Communes of Burundi, University of Toledo, Business administration, Jackson Center, University, Region, Farmer, Management

ARCHBOLD, Ohio, Sept. 21, 2023 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) announced the appointment of Doug Shaw, Jr. as the Regional President of its Southern Ohio market.

Key Points: 
  • ARCHBOLD, Ohio, Sept. 21, 2023 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) announced the appointment of Doug Shaw, Jr. as the Regional President of its Southern Ohio market.
  • Lars Eller, President and Chief Executive Officer stated, “Doug has been a valuable member of F&M's Commercial Lending team for nearly 10 years.
  • “I’m eager to move to the area and get to know the market, just as I’ve been able to do in F&M’s legacy Northwest Ohio market.
  • F&M’s footprint continues to grow, and I’m excited to execute strategies to meet our business objectives in Southern Ohio and the surrounding markets,” said Shaw.

Toledo Solar Wins $8.8 Federal Grant To Make See-Through Solar Windows, a near-term solution for Net Positive Buildings

Retrieved on: 
Monday, May 1, 2023
University, U.S. Department of Energy, Office of Inspector General, National Renewable Energy Laboratory, Partnership, Commercialization, University of Toledo, MWH, Architecture, DOE, Primary energy, PV, Kilowatt-hour, Car, Hotbed, Utility-scale solar, TSI, Glass, Cadmium telluride, NREL, Renewable energy, Silicon

The DOE's award to Toledo Solar reflects their commitment to drive American innovation to meet the nation's evolving electrical demand from domestically manufactured and renewable sources.

Key Points: 
  • The DOE's award to Toledo Solar reflects their commitment to drive American innovation to meet the nation's evolving electrical demand from domestically manufactured and renewable sources.
  • This award represents the largest investment of its kind to a solar panel manufacturer as part of the SETO Fiscal Year 2022 Solar Manufacturing Incubator.
  • The development of semi-transparent solar glass will allow markets that utilize traditional glass to incorporate an energy generation solution.
  • Solar generation has increased 73 times over that same period, from 2 million MWh to 146 million MWh.

SmithGroup Extends Great Lakes Design Expertise to Cleveland

Retrieved on: 
Tuesday, April 18, 2023
Cleveland State University, University, Education, SmithGroup, Great Lakes, Great Lakes region, Science, Suite, City, Risk, University of Toledo, Architecture, Principal, Transport, Metroparks Toledo, Geography, Industrial design

Cleveland, April 18, 2023 (GLOBE NEWSWIRE) -- SmithGroup , one of the nation’s leading integrated design firms, has opened its newest office in Cleveland.

Key Points: 
  • Cleveland, April 18, 2023 (GLOBE NEWSWIRE) -- SmithGroup , one of the nation’s leading integrated design firms, has opened its newest office in Cleveland.
  • SmithGroup’s Cleveland office team includes Principal landscape architect Chad Brintnall; senior planner and waterfront strategist Michelle Johnson; and landscape architect, architect and planner Marisa Razi.
  • “This new office expands our geographic footprint in the Great Lakes region and enables us to better connect our team with local communities.”
    SmithGroup’s Cleveland office is located at 1240 Huron Road East, Suite 410.
  • SmithGroup creates exceptional design solutions for healthcare, science and technology organizations, higher education and cultural institutions, urban environments, diverse workplaces, mixed-use and waterfront developments, and parks and open spaces.

VGI Medical, LLC Announces FDA Clearance of the Novel 3D Printed SiJoin® T3 Implant System, for Sacroiliac Joint Transfixation

Retrieved on: 
Tuesday, April 18, 2023
VGI, SI, US FDA, Ilium, Rotation, University of Toledo, 3D, Quality of life, Titanium, Pain, US, Patient, University, Sacrum, Medical device

LARGO, Fla., April 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC announces the new US FDA 510(k) cleared SiJoin®  Triangular Trabecular Titanium (T3) Implant System. The transfixing SiJoin®  T3 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the trabecular construction is engineered to mimic cancellous bone structure. The SiJoin®  T3 Implant is engineered with a dual geometric shape designed to be implanted within the plane of the SI joint, simultaneously positioned within the cortical walls of the ilium and sacrum, providing high surface area contact for transfixation. The implant is held against rotation via the stabilizer fins positioned between the opposing ilium and sacrum surfaces, and the non-circular cross-section of the main body. The novel design of the SiJoin®  T3 Implant fixes the ilium and sacrum relative to one another, maintaining the anatomical spacing of the SI joint, providing mechanical support by transfixing the SI joint while biologic fusion occurs.

Key Points: 
  • VGI Medical, LLC announces it has received 510(k) clearance from the United States Food and Drug Administration to market the transfixing SiJoin® Triangular Trabecular Titanium (T3) Implant System.
  • LARGO, Fla., April 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC announces the new US FDA 510(k) cleared SiJoin® Triangular Trabecular Titanium (T3) Implant System.
  • Specialized SiJoin® directional instrumentation deploys the implant into the SI joint, positioned across the joint, within the ilium and sacrum for transfixing of the SI joint.
  • We are excited to provide an advancement of this existing technology by incorporating the benefits of a 3D printed titanium implant–.

NextGen Healthcare to Highlight Interoperability and Health Equity at Top Healthcare Technology Events

Retrieved on: 
Wednesday, March 15, 2023
Software, Practice Management, Telemedicine, Virtual Medicine, Managed Care, Health, Data Management, Health Technology, Technology, Booth, NextGen Healthcare, University of Toledo, Patient, ViVe, Health equity, Venice Family Clinic, Snowflake, EHR, HIMSS, CST, University, Digital technology, Pharmaceutical industry, Asset management, United States Department of Agriculture South Building

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its participation in two industry-leading healthcare technology conferences, ViVE 2023 and HIMSS 23.

Key Points: 
  • NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its participation in two industry-leading healthcare technology conferences, ViVE 2023 and HIMSS 23.
  • The company will showcase how it enables interoperability and health equity across the industry in speaker sessions and booth demonstrations at both events.
  • NextGen Healthcare is a premiere sponsor of the InteropNOW!
  • NextGen Healthcare clients Venice Family Clinic and Neighborhood Health will participate in the discussion, which was also selected to be included in the HIMSS Health Equity Series .

Erie Home Appoints Jenilee Common as Chief Executive Officer

Retrieved on: 
Tuesday, March 14, 2023
History, Component, Entrepreneurship, Building material, Rest, National Agency for Controlled Materials (Argentina), Controller, Culture, Owens Corning, Eaton Corporation, Virginia Tech, Growth, University, Common, Partnership, Business, University of Toledo, Canal, Management

TOLEDO, Ohio, March 14, 2023 /PRNewswire/ -- Erie Home, a leading direct-to-consumer home solutions platform focused on providing residential re-roofing solutions in North America, today announced that it has appointed Jenilee Common as Chief Executive Officer. Pat Trompeter, Erie Home's Founder and former CEO, has been elevated to Chairman of the Board, while Randy Hamilton will continue to support the company's growth as President. The Erie Home team is excited to welcome Common's leadership in building world-class, multi-billion dollar businesses in the home improvement industry while honoring the legacy that Pat, Randy and the Erie Home team have built over the past 40 years.

Key Points: 
  • TOLEDO, Ohio, March 14, 2023 /PRNewswire/ -- Erie Home, a leading direct-to-consumer home solutions platform focused on providing residential re-roofing solutions in North America, today announced that it has appointed Jenilee Common as Chief Executive Officer.
  • Common brings over 20 years of experience in P&L leadership, sales, business strategy, pricing, supply chain management, and finance.
  • "I look forward to continuing to support Jenilee and Erie Home through its next chapter of growth in my role as Chairman."
  • "We are thrilled to welcome Jenilee as the new CEO of Erie Home and continue our partnership with Pat, Randy and the entire Erie Home team.

Hydromer Inc., Announces the Addition of Cam Cruickshank, Ph.D. to the Company’s Board of Directors, Replacing the Retiring Mr. Dieter Heinemann

Retrieved on: 
Wednesday, January 11, 2023
Business administration, Disagreement, Master of Business Administration, Hospital, The Salvation Army, University, Bachelor of Science in Nursing, Doctor of Philosophy, Cabarrus College of Health Sciences, Madonna University, Financial management, Educational technology, Cabarrus County, North Carolina, Tiffin University, Education, Greater, Marketing, University of Toledo, Committee on Finance, Bowling Green State University, Outline of health sciences, Medicine, Management

Cam Cruickshank, Ph.D. currently serves as the President of Cabarrus College of Health Sciences, a part of Advocate Health, which is the fifth-largest hospital network in the United States.

Key Points: 
  • Cam Cruickshank, Ph.D. currently serves as the President of Cabarrus College of Health Sciences, a part of Advocate Health, which is the fifth-largest hospital network in the United States.
  • Dr. Cruickshank works at Cabarrus College’s hospital campus located in Concord, North Carolina and has held this position since March 2020.
  • As the Chief Enrollment Officer at The University of Toledo, Cam was responsible for developing marketing, recruitment, financial aid, and retention strategies.
  • Cam Cruickshank, Ph.D. serves as the fifth member of the Hydromer Board of Directors and is replacing Mr. Dieter Heineman (88) who steadfastly and loyally served on the Hydromer Board since 1991.